What are the latest advancements in acute myeloid leukemia therapy? - Wikidata - wikimedia - TriplyDB

What are the latest advancements in acute myeloid leukemia therapy?

What are the latest advancements in acute myeloid leukemia therapy?

http://www.wikidata.org/entity/Q38749830

about

What are the latest advancements in acute myeloid leukemia therapy?

http://www.wikidata.org/entity/Q38749830

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

What are the latest advancements in acute myeloid leukemia therapy?

@en

type

label

What are the latest advancements in acute myeloid leukemia therapy?

@en

prefLabel

What are the latest advancements in acute myeloid leukemia therapy?

@en

P1433

Q38749830-51F5CE02-E38B-40FE-AAB9-B2EEB50755EC

P1476

Q38749830-8B941B7B-5442-44F2-9C3A-454BF7CFCABF

P2093

Q38749830-E3115599-5929-446D-86B3-A548462A65FB

Q38749830-EAF579E9-4772-4291-8BB8-67BA3EA40D36

P2860

Q38749830-21B00E11-905B-49DD-9AB0-C919FE4650C3

Q38749830-234BFB31-AB40-4D27-8701-A172B0C6E84E

Q38749830-2656E79F-6032-4447-BE5E-02DEB77B641D

Q38749830-406F5562-1D50-4BDA-8284-BF84646210C9

Q38749830-5280C1FE-C047-4D0E-BFA6-D023339A3DB9

Q38749830-73B85E3A-50C0-496A-83D3-695A52C2EB79

Q38749830-87B15FFF-AABD-44BE-A185-F27DC626C2B0

Q38749830-92C5D317-F86F-4DD4-98FE-ACAA849EF69C

Q38749830-A9AC1525-6CA1-4B46-B74C-F6C2E3CAD560

Q38749830-D005A4A9-1F2D-4180-BB2D-997A932AD4E6

P304

Q38749830-D52DCDD8-7354-4BCF-B264-06BFE9B9BEF4

P31

Q38749830-D1A1B0EC-3E85-4484-9C59-1E11B0796769

P356

Q38749830-BAE8C743-ACC8-43C2-97C2-DB3004C287C9

P407

Q38749830-DED87DC2-6868-4BCC-A9D8-D927D78EE685

P433

Q38749830-4756E466-ECA2-4DBC-9F7C-58509DE49A55

P478

Q38749830-ECCCC5F2-7B6C-4968-B6FC-E5262BD39A54

P577

Q38749830-B9B839F6-3AD5-4BC9-A5B7-3F5D5D323A9C

P698

Q38749830-06FD754E-9F80-4AAB-B75C-356AC0CB3B48

P356

P1433

Future Oncology

P1476

What are the latest advancements in acute myeloid leukemia therapy?

@en

P2093

Aaron Goodman

http://www.w3.org/2001/XMLSchema#string

Edward D Ball

http://www.w3.org/2001/XMLSchema#string

P2860

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

Acute Myeloid Leukemia

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.

Molecular therapy for acute myeloid leukaemia.

Driving CAR T-cells forward

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies.

Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?

Ipilimumab for Patients with Relapse after Allogeneic Transplantation.

Haploidentical hematopoietic transplantation: current status and future perspectives.

P304

867-871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2016-0555

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28266249

http://www.w3.org/2001/XMLSchema#string